Methods of assessing the impact of climacteric complaints on quality of life

Maturitas

Volumn 29, Issue 1, 1998, Pages 41-50

  Wiklund, Ingela ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Climacteric symptoms; Measurement; Menopause; Methods; Quality of life

Indexed keywords

ESTROGEN;

CLIMACTERIUM; COGNITION; ESTROGEN THERAPY; FEMALE; HUMAN; METHODOLOGY; MOOD; PSYCHOMETRY; QUALITY OF LIFE; RATING SCALE; REVIEW; SEXUAL FUNCTION; SLEEP DISORDER; STATISTICS; SYMPTOM; WELLBEING;

EID: 0032550697     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(98)00027-9     Document Type: Article

References (63)

1. Spitzer WO State of science 1986: quality of life and functional status as target variables for research. J Chron Dis. 40:1987;465-471.
2. Guyatt GM Methodologic problems in clinical trials in heart failure. J Chron Dis. 38:1985;353-363.
3. Wiklund I, Comerford MB, Dimenäs E The relationship between exercise tolerance and quality of life in angina pectoris. Clin Cardiol. 14:1991;204-208.
4. Guyatt G, Veldhuyzen Van Zanten S, Feeny D, Patrick D Measuring quality of life in clinical trials: a taxonomy and review. Can Med Assoc J. 140:1989;1441-1448.
5. Palmore E, Linkhardt C Health and social factors related to life satisfaction. J Health Soc Behav. 13:1972;68-80.
6. McKinlay JB, McKinlay SM, Brambilla D The relative contribution of endocrine changes and social circumstances in mid-aged women. J Health Soc Behav. 28:1987;345-363.
7. Greene JG. The Social and Psychological Origins of the Climacteric Syndrome. Aldershot: Gower Press, 1984.
8. Holte A, Mikkelsen A Psychosocial determinants of climacteric complaints. Maturitas. 13:1991;205-215.
9. McKinlay JB, McKinlay SM, Brambilla D Health status and utilization behaviour associated with menopause. Am J Epidemiol. 125:1987;110-121.
10. Harris RB, Laws A, Reddy VM, King A, Haskell WL Are women using postmenopausal estrogens? A community survey. Am J Publ Health. 80:1990;1266-1268.
11. Booher DL Estrogen supplements in menopause. Clevel Clin J Med. 57:1990;154-160.
12. Moorhead T, Hannaford P, Warskyj M Prevalence and characteristics associated with use of hormone replacement therapy in Britain. Br J Obstet Gynaecol. 104:1997;290-297.
13. Cheung AP, Wren BG A cost-effectiveness analysis of hormone replacement therapy in the menopause. Med J Aust. 156:1992;312-316.
14. Tostesson ANA, Weinstein MC Cost-effectiveness of hormone replacement therapy after the menopause. Baillière's Clin Obstet Gynaecol. 5:1991;943-959.
15. Fitzpatrick R, Fletcher A, Gose S, Jones D, Spiegelhalter D, Cox D Quality of life measures in health care. I: Applications and issues in assessment. Br Med J. 305:1992;1074-1077.
16. Fallowfield L, Baum M, Maguire GP Do psychological studies upset patients? J Roy Soc Med. 80:1987;59.
17. Aaronson N Quality of life assessments in clinical trials: methodological issues. Control Clin Trials. 10:1989;S195-208.
18. Wiklund I, Dimenäs E, Wahl M Factors of importance when evaluating quality of life in clinical trials. Control Clin Trials. 11:1990;169-179.
19. Hunt S, McEwen J, McKenna S. Measuring Health Status. London: Croom Helm, 1986.
20. Bergner M, Bobbitt R, Carter W, Gilson B The sickness impact profile: development and final revision of a health status measure. Med Care. 19:1981;787-805.
21. Patrick DL, Deyo RA Generic and disease-specific measures in assessing health status and quality of life. Med Care. 27:1989;217-232.
22. Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A, Mowat A Importance of sensitivity to change as a criterion for selecting health status measures. Qual Health Care. 1:1992;89-93.
23. Wiklund I, Karlberg J Evaluation of quality of life in clinical trials. Selecting QoL measures. Control Clin Trials. 12:1991;S204-216.
24. Hunter M, Battersby R, Whitehead M Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas. 8:1986;217-228.
25. Wiklund I, Berg G, Hammar M, Karlberg J, Lindgren R, Sandin K Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. Maturitas. 14:1992;225-236.
26. Wiklund I, Karlberg J, Mattson L-Å Quality of life during transdermal oestradiol therapy in postmenopausal women. A double-blind, placebo- controlled study. Am J Obstet Gynaecol. 168:1993;824-830.
27. Limouzin-Lamothe MA, Mairon N, Joyce CRB, Le Gal M Quality of life after the menopause: influence of hormonal replacement therapy. Am J Obstet Gynecol. 170:1994;618-624.
28. Hilditch JR, Lewis J, Peter Aet al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas. 24:1996;161-175.
29. Hilditch JR, Lewis J, Ross AHet al. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17β combined with an oral progestin on quality of life in postmenopausal women. Maturitas. 24:1996;177-184.
30. McCoy NL, Davidson JM A longitudinal study of the effects of menopause on sexuality. Maturitas. 7:1985;203-210.
31. Jenkins CD, Stanton B-A, Niencryk SJ, Rose RM A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol. 41:1988;313-321.
32. Melzack R The McGill pain questionnaire: major properties and scoring methods. Pain. 1:1975;277-299.
33. Beck AP. Depression: Clinical, Experimental and Therapeutic Aspects. New York: Harper and Row, 1967.
34. Goldberg DP. The Detection of Psychiatric Illness by Questionnaire. London: Oxford University Press, 1972.
35. Hamilton M A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1959;56-62.
36. Holte A Influences of natural menopause on health complaints: A prospective study of healthy Norwegian women. Maturitas. 14:1992;127-141.
37. Nicol-Smith L Causality, menopause and depression: a critical review of the literature. Br Med J. 313:1996;1229-1232.
38. Wiklund I, Holst J, Karlberg Jet al. A new methodological approach to the evaluation of quality of life in postmenopausal women. Maturitas. 14:1992;211-224.
39. Cox DR, Fitzpatrick R, Fletcher A, Gore SM, Spiegelhalter DJ, Jones DR Quality of life assessment: can we keep it simple? J R Statist Soc A. 155:1992;353-393.
40. Anon. Quality of life claims should not be based on open-label 'seeding' studies; FDA has continuing 'concerns' about quality of life claims in general. FDC Reports 1991;53:15-16.
41. MacKeigan L, Pathak DS Overview of health-related quality of life measures. Am J Hosp Pharm. 49:1992;2236-2245.
42. Fletcher AE, Gore S, Jones D, Fitzpatrick R, Speigelhalter D, Cox D Quality of life measures in health care. II: Design, analysis and interpretation. Br Med J. 305:1992;1145-1148.
43. Shumaker S anderson R, Czajhowski S. Psychological tests and scales. In: Spilker B, editor. Quality of Life Assessments in Clinical Trials. New York: Raven Press, 1990;95-113.
44. Wiklund I, Karlberg J, Sandin K, Mattson L-Å A Swedish version of the Women Health Questionnaire, a measure of postmenopausal complaints. Acta Obstet Gynaecol Scand. 72:1993;648-655.
45. Kirschner B, Guyatt G A methodological framework for assessing health indexes. J Chron Dis. 38:1975;27-36.
46. Kupperman HS, Blatt MHG, Wiesbader H, Filler W Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. Endocrinology. 13:1953;688-703.
47. Coope J Is estrogen therapy effective in treatment of menopausal depression? R Coll Gen Pract. 13:1981;134-140.
48. Utian WH. Menopause, hormone therapy and quality of life. In: CB Hammond, FP Haseltine, I Schiff, editors. Menopause. Progress in Clinical and Biological Research. New York: Alan R Liss, 1989;320:193-209.
49. Sindberg Eriksen P, Rasmussen H Low-dose 17β-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo-controlled study. Eur J Obstet Gynaecol Reprod Biol. 44:1992;137-144.
50. Foidart JM, Vervliet J, Buytaert P Efficacy of sustained-release vaginal oestriol in alleviating urogenital and systemic climacteric complaints. Maturitas. 13:1991;99-107.
51. Ballinger CB, Browning MCK, Smith AHW Hormone profiles and psychological symptoms in peri-menopausal women. Maturitas. 9:1987;235-251.
52. Campbell S, Whitehead M Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol. 4:1977;31-47.
53. Ditkoff EC, Crary W, Cristo M, Lobo RA Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynaecol. 78:1991;991-995.
54. Aitken RC Measurement of feelings using visual analogue scales. Proc Roy Soc Med. 2:1969;989-993.
55. Cutler WB, Garcia CR, McCoy N Perimenopausal sexuality. Arch Sex Behav. 16:1987;225-234.
56. Nathorst-Böös J, Wiklund I, Mattson L-Å, Sandin K, von Schoulz B Is sexual life influenced by transdermal estrogen therapy - a double blind placebo controlled study in postmenopausal women. Acta Obstet Gynecol Scand. 72:1993;656-660.
57. Dupuy HJ. The psychological general well-being (PGWB) index. In: Wenger NK, Mattson ME, Furberg CD, Elinson J, editors. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. USA: Le Jacq, 1984;170-183.
58. Dimenäs E, Carlsson G, Glise H, Israelsson B, Wiklund I Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol. 31(221):1996;S8-13.
59. Croog SH, Levine S, Testa MAet al. The effects of antihypertensive therapy on the quality of life. N Engl J Med. 314:1986;1657-1664.
60. Hunt SM, McEwen J, McKenna SP Perceived health. Age and sex norms in a community. J Epidemiol Commun Health. 38:1984;156-160.
61. Oldenhave A, Jaszmann LJB, Haspels AA, Everaerd WTAM Impact of climacteric on well-being. Am J Obstet Gynecol. 168:1993;772-780.
62. Ledésert B, Ringa V, Bréart G Menopause and perceived health status among the women of the French GAZEL cohort. Maturitas. 20:1995;113-120.
63. Karlberg J, Mattsson L-Å, Wiklund I A quality of life perspective on who benefits from estradiol replacement therapy. Acta Obstet Gynecol Scand. 74:1995;367-372.